Obesity in kidney disease: A heavyweight opponent. - Wikidata - thesis-toulmin - TriplyDB

Obesity in kidney disease: A heavyweight opponent.

Obesity in kidney disease: A heavyweight opponent.

http://www.wikidata.org/entity/Q34367664

about

Anti-Inflammatory Effects of Ang-(1-7) in Ameliorating HFD-Induced Renal Injury through LDLr-SREBP2-SCAP Pathway Precocious obesity predisposes the development of more severe cisplatin-induced acute kidney injury in young adult mice.Leptin deficiency down-regulates IL-23 production in glomerular podocytes resulting in an attenuated immune response in nephrotoxic serum nephritis.The kidney in obesity.Matrix Metalloproteinase Neutrophil Gelatinase-Associated Lipocalin Complex Predicts Atrial Fibrillation Recurrence after Electrical Cardioversion in Obese Patients.Urinary fibrogenic cytokines ET-1 and TGF-β1 are associated with urinary angiotensinogen levels in obese children.Obesity-related glomerulopathy: pathogenesis, pathologic, clinical characteristics and treatment.Protective Effects of Glucagon-Like Peptide-1 Analog on Renal Tubular Injury in Mice on High-Fat Diet.

P2860

Q27322539-134E15AB-EE33-482E-82E5-706C90F030C9 Q36328309-150B3FCA-EE37-4FD9-8720-95BDA7F021AD Q36958908-18A25BC6-5084-4E25-95DF-A48FA07C6A0E Q38429861-BD8E42AB-C1C4-45EE-903C-60AAF53BDB16 Q39085575-7E7E7E9A-2615-49B3-96D7-5470CB182CED Q41202467-AFE36763-5EB9-45AC-9D16-305C09329BAC Q48698019-44DC78D5-B112-4D67-BC86-0560A56D4B7A Q51118569-6A3382A5-2EB9-4258-B9D8-6D283244A084

P2860

Obesity in kidney disease: A heavyweight opponent.

http://www.wikidata.org/entity/Q34367664

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Obesity in kidney disease: A heavyweight opponent.

@ast

Obesity in kidney disease: A heavyweight opponent.

@en

Obesity in kidney disease: A heavyweight opponent.

@nl

type

label

Obesity in kidney disease: A heavyweight opponent.

@ast

Obesity in kidney disease: A heavyweight opponent.

@en

Obesity in kidney disease: A heavyweight opponent.

@nl

prefLabel

Obesity in kidney disease: A heavyweight opponent.

@ast

Obesity in kidney disease: A heavyweight opponent.

@en

Obesity in kidney disease: A heavyweight opponent.

@nl

P1433

Q34367664-C8BAE5DB-9CFA-47A0-9437-80FE3E6C0979

P1476

Q34367664-7F0875D0-5203-4E6D-B0CA-C6DFB0AB4FB6

P2093

Q34367664-887921C0-97C0-4AC9-A3E2-088038B49A75

Q34367664-A8693133-C874-4B0B-92D7-6D1850296EF2

Q34367664-D83A2201-376C-46BF-B4D8-EBB0C88362B9

Q34367664-EAE1CEC6-553A-4E2C-87F5-1B7D6742724F

P2860

Q34367664-0257B7C7-67FD-4292-AEC2-90B7CFE7EA69

Q34367664-02D4F2C9-4708-4C55-80B4-A3B21BA1E744

Q34367664-04654A4B-17A1-4DC8-8484-EE3186B47426

Q34367664-060FD6E5-C7F8-43AC-92C1-B96EEC223332

Q34367664-08E370FF-8B7C-4C30-834D-E673FD0E560F

Q34367664-0ABBD1B2-F89C-492A-9FA6-E30BA753EAE5

Q34367664-0C0442E3-F0F0-4FBA-BFE0-BEC408B9F2D7

Q34367664-0E41588B-7A93-4FBD-A6E7-C94B4830FF6D

Q34367664-0F5306B0-0E00-470A-9311-32F97E32E543

Q34367664-0FE6AECB-514E-4417-B3CA-F5949DC7D430

P304

Q34367664-72FD36A4-16B6-4C48-BF3D-25B9BD1D8555

P31

Q34367664-88E85A4B-E4D4-4C25-BC89-307EE4E0EA93

P356

Q34367664-7CCDE6A4-F291-4CB7-9460-ED999A397A82

P433

Q34367664-4060CF13-8273-47CF-9EC2-F537CA80AA4F

P478

Q34367664-070ACC64-256F-4ADE-A475-D147CBF733CF

P577

Q34367664-052987B3-9EF3-4EE3-96E0-286613AAFA80

P5875

Q34367664-EEBC02B1-3FF1-4034-8C43-91C509184781

P698

Q34367664-F33366A4-940C-4E73-A0C8-F819E6FABB59

P921

Q34367664-97FC7717-DB41-484C-AD31-6428DF1460D7

P932

Q34367664-63FB2CF5-D057-464D-8C35-2302EB7FD748

P356

P1433

World journal of nephrology

P1476

Obesity in kidney disease: A heavyweight opponent.

@en

P2093

Cristhiane Favero Aguiar

http://www.w3.org/2001/XMLSchema#string

Marina Burgos da Silva

http://www.w3.org/2001/XMLSchema#string

Niels Olsen Saraiva Câmara

http://www.w3.org/2001/XMLSchema#string

Raphael Jose Ferreira Felizardo

http://www.w3.org/2001/XMLSchema#string

P2860

Obesity and Risk for Chronic Renal Failure

Long-term drug treatment for obesity: a systematic and clinical review

Adiponectin regulates albuminuria and podocyte function in mice

B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

Diet-induced obesity in C57BL/6J mice causes increased renal lipid accumulation and glomerulosclerosis via a sterol regulatory element-binding protein-1c-dependent pathway

Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

P304

50-63

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5527/WJN.V3.I3.50

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2014-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267273626

http://www.w3.org/2001/XMLSchema#string

P698

25332896

http://www.w3.org/2001/XMLSchema#string

P921

P932

4202492

http://www.w3.org/2001/XMLSchema#string